• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

In vitro stepwise selection of resistance to quinolones, beta-lactams and amikacin in nosocomial gram-negative bacilli.

作者信息

Michéa-Hamzehpour M, Kahr A, Pechère J C

机构信息

Dept. of Genetics and Microbiology, Centre Médical Universitaire, University of Geneva, Switzerland.

出版信息

Infection. 1994;22 Suppl 2:S105-10. doi: 10.1007/BF01793574.

DOI:10.1007/BF01793574
PMID:7927828
Abstract

The ability of six antibiotics to produce resistance by stepwise selection on agar medium was assessed in 24 gram-negative rods. Escherichia coli was the strain least prone to selection of resistance, whereas Pseudomonas aeruginosa frequently developed resistance to all antibiotics. When used alone, ciprofloxacin, pefloxacin, amikacin, ceftazidime and cefpirome were associated with a comparable risk of acquired resistance (in 14 to 17 out of 24 strains); imipenem selected resistant strains in 10/24 isolates (5/18 in non-pseudomonas strains). The number of strains exhibiting cross resistance with structurally unrelated antibiotics was 11 after pefloxacin treatment, eight after exposure to ciprofloxacin, six after ceftazidime, and one after imipenem or cefpirome. The combination of ciprofloxacin with amikacin was less efficient in reducing acquisition of resistance than the combination of ciprofloxacin with a beta-lactam: ciprofloxacin plus cefpirome was especially potent in this respect.

摘要

相似文献

1
In vitro stepwise selection of resistance to quinolones, beta-lactams and amikacin in nosocomial gram-negative bacilli.
Infection. 1994;22 Suppl 2:S105-10. doi: 10.1007/BF01793574.
2
Cross-susceptibility of cefpirome and four other beta-lactams against isolates from haematology/oncology and intensive care units. International Study Group.头孢匹罗与其他四种β-内酰胺类药物对血液学/肿瘤学及重症监护病房分离菌株的交叉敏感性。国际研究小组。
Scand J Infect Dis Suppl. 1993;91:25-32.
3
Nosocomial outbreak due to a multiresistant strain of Pseudomonas aeruginosa P12: efficacy of cefepime-amikacin therapy and analysis of beta-lactam resistance.由多重耐药性铜绿假单胞菌P12菌株引起的医院感染暴发:头孢吡肟-阿米卡星治疗的疗效及β-内酰胺耐药性分析
J Clin Microbiol. 2001 Jun;39(6):2072-8. doi: 10.1128/JCM.39.6.2072-2078.2001.
4
Activity of amikacin, ertapenem, ciprofloxacin and levofloxacin alone and in combination against resistant nosocomial pathogens by time-kill.阿米卡星、厄他培南、环丙沙星和左氧氟沙星单独及联合应用对耐药医院病原体的时间杀菌活性。
West Indian Med J. 2008 Mar;57(2):106-11.
5
In vitro selection of resistance in Pseudomonas aeruginosa and Acinetobacter spp. by levofloxacin and ciprofloxacin alone and in combination with beta-lactams and amikacin.铜绿假单胞菌和不动杆菌属中左氧氟沙星、环丙沙星单独及与β-内酰胺类和阿米卡星联合使用时的体外耐药性选择
J Antimicrob Chemother. 2005 Aug;56(2):353-9. doi: 10.1093/jac/dki204. Epub 2005 Jun 20.
6
[Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study].[土耳其医院革兰氏阴性医院分离株对新型β-内酰胺类及相关超广谱β-内酰胺酶类型的耐药性:多中心HITIT研究结果]
Mikrobiyol Bul. 2008 Oct;42(4):537-44.
7
Activity of selected beta-lactams, ciprofloxacin, and amikacin against different Acinetobacter baumannii biotypes from Chilean hospitals.智利医院中所选β-内酰胺类抗生素、环丙沙星和阿米卡星对不同鲍曼不动杆菌生物型的活性。
Diagn Microbiol Infect Dis. 1997 Aug;28(4):183-6. doi: 10.1016/s0732-8893(97)00074-6.
8
[Pseudomonas aeruginosa: bactericidal activity on various beta-lactam resistance phenotypes of 8 antibiotics and 7 combinations].[铜绿假单胞菌:8种抗生素及7种联合用药对各种β-内酰胺耐药表型的杀菌活性]
Pathol Biol (Paris). 1997 May;45(5):433-7.
9
Fourth-generation cephalosporins: in vitro activity against nosocomial gram-negative bacilli compared with beta-lactam antibiotics and ciprofloxacin.
Chemotherapy. 2005 May;51(2-3):80-5. doi: 10.1159/000085614. Epub 2005 May 4.
10
In vitro potency of amikacin and comparators against E. coli, K. pneumoniae and P. aeruginosa respiratory and blood isolates.阿米卡星及对照药物对大肠杆菌、肺炎克雷伯菌和铜绿假单胞菌呼吸道及血液分离株的体外抗菌效力。
Ann Clin Microbiol Antimicrob. 2016 Jun 17;15(1):39. doi: 10.1186/s12941-016-0155-z.

引用本文的文献

1
Development of phage-based assay to differentiate ciprofloxacin resistant and sensitive Typhimurium.用于区分耐环丙沙星和敏感鼠伤寒沙门氏菌的基于噬菌体的检测方法的开发。
Food Sci Biotechnol. 2021 Jan 6;30(2):315-320. doi: 10.1007/s10068-020-00858-9. eCollection 2021 Feb.
2
Characterization of β-lactamase- and efflux pump-mediated multiple antibiotic resistance in Typhimurium.鼠伤寒沙门氏菌中β-内酰胺酶和外排泵介导的多重抗生素耐药性特征分析
Food Sci Biotechnol. 2018 Jan 13;27(3):921-928. doi: 10.1007/s10068-018-0317-1. eCollection 2018 Jun.
3
Evaluation of lytic bacteriophages for control of multidrug-resistant Salmonella Typhimurium.

本文引用的文献

1
Microbial Selection.微生物选择
Science. 1952 Jul 18;116(3003):45-51. doi: 10.1126/science.116.3003.45.
2
The relationship between antecedent antibiotic use and resistance to extended-spectrum cephalosporins in group I beta-lactamase-producing organisms.产I型β-内酰胺酶菌株中先前使用抗生素与对广谱头孢菌素耐药性之间的关系。
Clin Infect Dis. 1995 Nov;21(5):1107-13. doi: 10.1093/clinids/21.5.1107.
3
Sequential acquisition of norfloxacin and ofloxacin resistance by methicillin-resistant and -susceptible Staphylococcus aureus.
评价裂解噬菌体对控制多重耐药鼠伤寒沙门氏菌的效果。
Ann Clin Microbiol Antimicrob. 2017 Sep 22;16(1):66. doi: 10.1186/s12941-017-0237-6.
4
Differences in 23S ribosomal RNA mutations between wild-type and mutant macrolide-resistant isolates.野生型和大环内酯类耐药突变株之间23S核糖体RNA突变的差异。
Exp Ther Med. 2015 Sep;10(3):1189-1193. doi: 10.3892/etm.2015.2595. Epub 2015 Jun 24.
5
Efflux pump gene hefA of Helicobacter pylori plays an important role in multidrug resistance.幽门螺杆菌的外排泵基因hefA在多药耐药中起重要作用。
World J Gastroenterol. 2008 Sep 7;14(33):5217-22. doi: 10.3748/wjg.14.5217.
6
In vitro evaluation of antibiotics' combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureus severe respiratory infections.用于疑似耐甲氧西林金黄色葡萄球菌严重呼吸道感染经验性治疗的抗生素联合用药的体外评估
BMC Infect Dis. 2007 Sep 21;7:111. doi: 10.1186/1471-2334-7-111.
7
Cefpirome. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy in the treatment of severe nosocomial infections and febrile neutropenia.头孢匹罗。关于其抗菌活性、药代动力学特性及治疗严重医院感染和发热性中性粒细胞减少症临床疗效的综述。
Drugs. 1997 Jul;54(1):117-40. doi: 10.2165/00003495-199754010-00013.
8
Ciprofloxacin. An updated review of its pharmacology, therapeutic efficacy and tolerability.环丙沙星。对其药理学、治疗效果及耐受性的最新综述。
Drugs. 1996 Jun;51(6):1019-74. doi: 10.2165/00003495-199651060-00010.
耐甲氧西林和甲氧西林敏感金黄色葡萄球菌对诺氟沙星和氧氟沙星耐药性的序贯获得
Antimicrob Agents Chemother. 1993 Nov;37(11):2278-84. doi: 10.1128/AAC.37.11.2278.
4
Selection of multiple antibiotic resistance by quinolones, beta-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes.喹诺酮类、β-内酰胺类和氨基糖苷类药物对多重抗生素耐药性的选择,特别提及不相关药物类别之间的交叉耐药性。
Antimicrob Agents Chemother. 1984 Dec;26(6):797-801. doi: 10.1128/AAC.26.6.797.
5
Effect of a single dose of cefotaxime or ceftriaxone on human faecal flora. A double-blind study.单剂量头孢噻肟或头孢曲松对人体粪便菌群的影响。一项双盲研究。
Drugs. 1988;35 Suppl 2:6-11. doi: 10.2165/00003495-198800352-00004.
6
Development of resistance during antibiotic therapy.抗生素治疗期间耐药性的产生。
Eur J Clin Microbiol. 1987 Jun;6(3):234-44. doi: 10.1007/BF02017607.
7
Resistance occurring after fluoroquinolone therapy of experimental Pseudomonas aeruginosa peritonitis.实验性铜绿假单胞菌腹膜炎氟喹诺酮治疗后出现的耐药性。
Antimicrob Agents Chemother. 1987 Nov;31(11):1803-8. doi: 10.1128/AAC.31.11.1803.
8
Combination therapy: a way to limit emergence of resistance?
Am J Med. 1986 Jun 30;80(6B):138-42. doi: 10.1016/0002-9343(86)90491-2.
9
Cross-resistance to nalidixic acid, trimethoprim, and chloramphenicol associated with alterations in outer membrane proteins of Klebsiella, Enterobacter, and Serratia.与克雷伯菌属、肠杆菌属和沙雷菌属外膜蛋白改变相关的对萘啶酸、甲氧苄啶和氯霉素的交叉耐药性。
J Infect Dis. 1985 Mar;151(3):501-7. doi: 10.1093/infdis/151.3.501.
10
Restriction maps of the regions coding for methicillin and tobramycin resistances on chromosomal DNA in methicillin-resistant staphylococci.耐甲氧西林葡萄球菌染色体DNA上编码对甲氧西林和妥布霉素耐药性区域的限制酶切图谱。
Antimicrob Agents Chemother. 1989 Sep;33(9):1624-6. doi: 10.1128/AAC.33.9.1624.